CLCraig Marc Luetjens

Craig Marc Luetjens

*This is an algorithmically generated author record based on publicly available information.

Craig Marc Luetjens has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of Gadolinium‐Based Contrast Agents in Juvenile Non‐Human Primates Including Behavioral Evaluations Such as Learning and Memory

    by Daniela Smieja, Oliver Czupalla, Clemens Günther, Simona Bussi, Alessandra Coppo, Paul Jones, Matilde Forni, Nathalie Fretellier, Philippe Bourrinet, C. Marc Luetjens

    Background: The US Food and Drug Administration (FDA) requested the four Gadolinium‐Based Contrast Agents (GBCA) New Drug Application (NDA) holders to investigate the effects of gadolinium (Gd) retention on fetal and neonatal development in mice and juvenile non‐human primates (NHP) as well as the effects of repeated GBCA administrations on behavioral, neurological, and histopathological endpoints.Methods: Two linear (gadodiamide and gadobenate dimeglumine) and one macrocyclic (gadobutrol) GBCA, intended to be representative of linear non‐ionic, linear ionic, and macrocyclic GBCAs, were investigated in a juvenile toxicity study in the cynomolgus monkey. Clinical observations, body weight, food consumption, clinical chemistry, full histopathology, and behavioral/neurological parameters including learning and memory were assessed. Additionally, Gd was quantified in the brain and other selected organs/tissues. A total of 84 juvenile animals (n = 12/group) were intravenously dosed every 4 weeks from postnatal day 28 for a total of 8 administrations over 29 weeks. Evaluation at the end of dosing, or after a recovery phase, was conducted to assess the reversibility of any observed effects. Necropsy was performed on Day 198 of the dosing phase for four animals/group and Day 365 of the recovery phase for the remaining eight animals/group.Results: No GBCA‐related adverse effects were observed in juvenile cynomolgus monkeys either at the end of the dosing or recovery periods. The no‐observed‐effect‐levels (NOEL) for gadobutrol and gadodiamide administration were 0.9 mmol/kg and, for gadobenate dimeglumine, 0.3 mmol/kg (due to a non‐adverse difference in learning during the recovery phase in the high dose group). The no‐observed‐adverse‐effect‐level (NOAEL) for all GBCAs was established as at least 0.9 mmol/kg.Conclusions: Gd levels observed in brain tissue of cynomolgus monkey after juvenile exposure to multiples of equivalent clinical doses of all GBCAs tested did not correlate with any adverse morphological or functional findings. This study showed no evidence that exposure to GBCA during development presents a potential risk for long‐term effects such as behavioral, neurological, or histopathological findings in the brain, and/or impaired learning or memory.


  • Open Access

    Enhanced normograms and pregnancy outcome analysis in nonhuman primate developmental toxicity studies

    by Heiko Grossmann, Gerhard F. Weinbauer, Ann Baker, Antje Fuchs, C. Marc Luetjens


  • Maternal or fetal origin of rhesus monkey (Macaca mulatta) amniotic fluid leukocytes can be identified by polymerase chain reaction using the zinc finger Y gene

    by A.E. Macias, S.W. Wong, D.W. Sadowsky, C.M. Luetjens, M.K. Axthelm, M.G. Gravett, G.J. Haluska, M.J. Novy

    Leukocytes can be found in substantial numbers within the intrauterine tissues and amniotic fluid of women, and play a central role in the pathophysiology of infection‐related preterm labor by their production of proinflammatory mediators. It remains unclear whether these leukocytes represent a fetal immune response, a maternal response, or a combination of the two. The objective of this study was to develop a test in the rhesus monkey (Macaca mulatta) suitable for determining the percentage of male fetal cells present in a population of leukocytes recovered from blood or amniotic fluid. We found inadequate specificity for rhesus monkey cells using commercial human Y‐chromosome paint kits (fluorescence in situ hybridization (FISH)). Human‐specific primers for the repetitive Y chromosome DYZ‐1 locus employed in the polymerase chain reaction (PCR) produced an unacceptable percentage of false positives. However, we successfully developed a PCR‐based test using rhesus‐specific primers for the zinc finger Y (ZFY) locus. Densitometry of PCR products from known ratios of male and female adult peripheral leukocytes generated a linear standard curve which provided quantitative results and required only 400 cells per sample. The rhesus beta globin (RBG) gene served as an internal control. The PCR test correctly discriminated the sex of peripheral leukocytes in 20 adult males, 20 adult females, two male fetuses, and one female fetus. Serial samples of amniotic fluid from four chronically catheterized rhesus monkeys bearing male fetuses were used to confirm the utility of this assay for quantifying fetal cells in amniotic fluid. In conclusion, we have developed a PCR test which is suitable for distinguishing male from female cells in adult and fetal blood and in amniotic fluid, which lends itself to a variety of diagnostic and biologic applications in the rhesus monkey and potentially in other nonhuman primates. Am. J. Primatol. 55:159–170, 2001.